This study is looking at whether taking carnosine (2 grams per day) for three months can help men with Peripheral Arterial Disease (PAD) walk better. PAD is a condition where narrowed arteries reduce blood flow to your limbs, often causing leg pain when walking. Researchers believe carnosine might improve blood flow by helping new blood vessels grow (angiogenesis). The study will measure walking ability after one year. You may be eligible if you are a white or African American man between 50 and 80 years old, speak English, and have a specific ankle-brachial index (ABI) between 0.4 and less than 0.60. The study plans to enroll 20 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 20 men.

What's involved

Participants will take carnosine daily for 3 months. The primary outcome will be measured at one year.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for one year after starting the carnosine supplementation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.